Frankfurt - Delayed Quote EUR
Voyager Therapeutics, Inc. (VT6.F)
2.7000
-0.0200
(-0.74%)
At close: April 22 at 8:19:36 AM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-15,310
-15,310
77,919
-12,509
-53,525
Investing Cash Flow
-94,859
-94,859
-141,643
-7,339
65,906
Financing Cash Flow
114,015
114,015
33,645
1,110
612
End Cash Position
74,241
74,241
70,395
100,474
119,212
Capital Expenditure
-3,521
-3,521
-3,256
-2,491
-1,609
Issuance of Capital Stock
112,778
112,778
31,121
--
--
Free Cash Flow
-18,831
-18,831
74,663
-15,000
-55,134
12/31/2021 - 11/19/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
0K4.F Akero Therapeutics, Inc.
33.55
+1.70%
THER Theralink Technologies, Inc.
0.0001
0.00%
VVY.AS Vivoryon Therapeutics N.V.
1.7900
+2.17%
PRTC.L PureTech Health plc
132.60
+7.46%
CYCN Cyclerion Therapeutics, Inc.
2.9900
+10.74%
ZNTL Zentalis Pharmaceuticals, Inc.
1.4700
+8.09%
VLA.PA Valneva SE
3.1100
+2.44%
GRI GRI Bio, Inc.
1.4500
-0.68%
BTAI BioXcel Therapeutics, Inc.
1.6800
-1.75%
MGNX MacroGenics, Inc.
1.5200
+9.35%